Director Sells 33,000 Impinj: Insider Move to Watch
A high-profile insider move hits Impinj as a director sells 33,000 impinj shares. Learn what this signals, how to ana...
Which Travel Cards Have No Annual Fee
Explore a variety of travel cards that charge no annual fees. Save on costs while maximizing your travel rewards.
26,784 articles
Markets React as Million Openings Just Landed Today
May data show 7.6 million job openings, topping forecasts and signaling stabilization in the labor market. Thursday's...
Brutal Heatwave France Killing Budgets and Health Costs
France confronts a brutal heatwave as weekly deaths rise by 29% amid record temperatures. The health and funeral sect...
Warren Buffett's Successor, Greg, Bets on AI Stock Soaring
Greg Abel, the man tapped to carry on Warren Buffett's investing legacy, is making a bold AI move with Alphabet. Berk...
Bezos’ Blue Origin Raising Outside Capital to Compete
Blue Origin plans a $10 billion round at a $130 billion valuation, backed by Jeff Bezos and institutional investors. ...
Dave Ramsey Says Early 401(K) Withdrawals Cost Too Much
Dave Ramsey renews warnings against raiding retirement savings to pay debt. This report explains the costs and lays o...
Wendy’s McDonald’s: Wendy’s Ride to Short-Squeeze Momentum
Wendy’s faces traffic losses even as it pursues a turnaround with Project Fresh, while McDonald’s leans on loyalty an...
Japan’s Rally Without Risk: Hedged Fund Beats EWJ This Year
A yen-hedged approach to Japan equities outperformed the unhedged EWJ by roughly six percentage points in the first h...
Nvidia’s AI Moat Drives My Biggest Reason I’m Buying
NVIDIA’s latest results highlight a powerful software moat and growing AI infrastructure demand, underscoring why man...
Why Netflix Stock Fell This Past Week: Key Insights
When netflix stock fell this past week, investors looked beyond headline results to the quality of communication from...
Why ASML Stock Jumped First Half 2026: A Deep Dive
In the first half of 2026, ASML delivered a standout rally as AI-driven demand lifted the semiconductor supply chain....
Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status